IL6 and cancer: Among the pathways in cancer indicated by KEGG analysis, the upregulated miR-222 was involved in pivotal pathways, such as OSM, IL-6 and ERK/MAPK signaling pathways in breast cancer [58], known pathways to be activated in IBC [59, 60].